Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
501
DELISTED
Cardiovascular Systems, Inc.
CSII
| $12.5M | 0.01% |
472,831
-175,459
| -27% | -$5.67M |
|
|
DCOY
502
Decoy Therapeutics
DCOY
$2.14M
| $12.4M | 0.01% |
1
| – | – |
|
503
Targa Resources
TRGP
$56.8B
| $12M | 0.01% |
134,780
-435,963
| -76% | -$42.6M |
|
|
TUES
504
DELISTED
Tuesday Morning Corp
TUES
| $12M | 0.01% |
1,061,197
-33,274
| -3% | -$484K |
|
|
FENX
505
DELISTED
Fenix Parts, Inc.
FENX
| $11.8M | 0.01% |
+1,181,821
| New | +$12.3M |
|
506
Douglas Emmett
DEI
$2.05B
| $11.7M | 0.01% |
433,333
-5,505
| -1% | -$159K |
|
|
BKI
507
DELISTED
Black Knight, Inc. Common Stock
BKI
| $11.6M | 0.01% |
+376,020
| New | +$10.9M |
|
508
Owens Corning
OC
$11B
| $11.5M | 0.01% |
+277,909
| New | +$11.4M |
|
|
ROIC
509
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $11.1M | 0.01% |
710,502
+425,283
| +149% | +$7.12M |
|
|
WBC
510
DELISTED
WABCO HOLDINGS INC.
WBC
| $10.9M | 0.01% |
88,409
+2,722
| +3% | +$343K |
|
511
Sarepta Therapeutics
SRPT
$1.64B
| $10.7M | 0.01% |
+353,000
| New | +$7.22M |
|
512
Qualys
QLYS
$4.76B
| $10.5M | 0.01% |
259,063
-9,929
| -4% | -$446K |
|
|
PSXP
513
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $10.4M | 0.01% |
144,573
+43,373
| +43% | +$3.13M |
|
514
Coherus Oncology
CHRS
$217M
| $10.2M | 0.01% |
+353,363
| New | +$8.93M |
|
|
RLYP
515
DELISTED
RELYPSA INC COM
RLYP
| $10M | 0.01% |
302,200
+1,998
| +0.7% | +$68.7K |
|
516
Century Aluminum
CENX
$4.22B
| $9.93M | 0.01% |
952,285
+19,700
| +2% | +$251K |
|
517
MPLX
MPLX
$58.6B
| $9.83M | 0.01% |
137,735
+47,676
| +53% | +$3.53M |
|
|
ACOR
518
DELISTED
Acorda Therapeutics
ACOR
| $9.01M | 0.01% |
2,252
-1,060
| -32% | -$4.09M |
|
|
DERM
519
DELISTED
Dermira, Inc.
DERM
| $8.95M | 0.01% |
510,106
+2,403
| +0.5% | +$37.1K |
|
520
FerroAtlántica
GSM
$590M
| $8.89M | 0.01% |
+502,418
| New | +$10M |
|
|
PRTY
521
DELISTED
Party City Holdco Inc.
PRTY
| $8.64M | 0.01% |
+426,241
| New | +$9.1M |
|
|
ALPN
522
DELISTED
Alpine Immune Sciences Inc
ALPN
| $8.53M | 0.01% |
+144,296
| New | +$8.59M |
|
|
ETP
523
DELISTED
Energy Transfer Partners L.p.
ETP
| $8.2M | 0.01% |
157,171
+47,870
| +44% | +$2.67M |
|
|
DSCI
524
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $8.17M | 0.01% |
1,140,446
+3,518
| +0.3% | +$26.5K |
|
|
ACGN
525
DELISTED
Aceragen Inc
ACGN
| $8M | 0.01% |
15,879
+117
| +0.7% | +$53.7K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.